Theodorus Funds are venture capital funds dedicated to early-stage tech investments. It invests mostly in Biotech, MedTech & AI companies with proprietary technologies.
Besides its financing role, Theodorus also plays an active role in the development of its portfolio companies, guiding the company towards its success.
Today, Theodorus holds 70M€ of assets under management, which helped fund >40 companies and create >700 M€ in value. Theodorus has offices in Montreal and Brussels.
In 2022, Theodorus gave its support to Domain Therapeutics and invested in the group to support its advancement to the clinic stage.